Search Results - "Menor Almagro, Raúl"
-
1
P147 Is belimumab dose optimization possible in patients with systemic lupus erythematosus? Analysis of this therapeutic strategy in a large multicenter cohort of patients from Spanish rheumatology departments
Published in Lupus science & medicine (14-03-2024)“…ObjectiveTo assess the prevalence of dose optimization in patients with SLE treated with BLM, its modalities and its impact on disease activity…”
Get full text
Journal Article -
2
O2 Serious infection, including severe COVID19, seems not to be a major clinical problem in patients with systemic lupus erythematosus treated with Belimumab, according the data from a large multicenter cohort
Published in Lupus science & medicine (14-03-2024)“…ObjectivesBelimumab (BLM) had been shown to be consistently effective in patients with systemic lupus erythematosus (SLE) and is increasingly being used…”
Get full text
Journal Article -
3
Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain
Published in Reumatologia clinica (01-09-2016)“…Abstract Objective Several antibodies have proven to be useful in autoimmune diseases, as markers for diagnosis, prognosis or clinical manifestations. Our…”
Get full text
Journal Article -
4
Association between antinuclear antibody titers and connective tissue diseases in a Rheumatology Department
Published in Reumatologia clinica (01-05-2017)“…To determine the dilution titles at antinuclear antibodies (ANA) by indirect immunofluorescence observed in cell substrate HEp-2 and its association with the…”
Get more information
Journal Article -
5
Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?
Published in Rheumatology (Oxford, England) (04-01-2024)“…To assess agreement between the 2021 Definition Of Remission In SLE (DORIS) and physician-judged lupus activity. A cross-sectional analysis was conducted of…”
Get full text
Journal Article -
6
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
Published in Lupus (01-10-2020)“…Introduction Antiphospholipid antibodies (aPL) have been associated with organ damage and certain features in systemic lupus erythematosus(SLE) patients. Our…”
Get full text
Journal Article -
7
Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?
Published in Rheumatology (Oxford, England) (03-11-2021)“…SLE can affect any part of the gastrointestinal (GI) tract. GI symptoms are reported to occur in >50% of SLE patients. To describe the GI manifestations of SLE…”
Get full text
Journal Article -
8
Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)
Published in Rheumatology international (01-11-2024)“…Introduction: Diffuse alveolar hemorrhage (DAH) is a rare complication with high mortality in patients with systemic lupus erythematosus (SLE). Early…”
Get full text
Journal Article -
9
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Published in Seminars in arthritis and rheumatism (01-02-2023)“…•Major CNS NP-SLE contributes to a 2-times higher mortality in SLE.•The individual major CNS NP-SLE manifestations contribute differently to survival in…”
Get full text
Journal Article -
10
Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure
Published in Seminars in arthritis and rheumatism (01-02-2022)“…Factors associated with chronic heart failure (CHF) in patients with systemic lupus erythematosus (SLE) have received little attention. Recent data on the use…”
Get full text
Journal Article -
11
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort
Published in Lupus science & medicine (08-04-2024)“…ObjectiveTo develop an improved score for prediction of severe infection in patients with systemic lupus erythematosus (SLE), namely, the SLE Severe Infection…”
Get full text
Journal Article -
12
P129 Does the perspective of SLE patients match the expert opinion and definitions of remission and low disease activity state? Prospective analysis of 500 patients from a Spanish multicenter cohort
Published in Lupus science & medicine (14-03-2024)“…BackgroundNo data on agreement between patient perception, DORIS 2021 remission, LLDAS, or physician assessment is currently available.The aim is to compare…”
Get full text
Journal Article -
13
68 years old woman with right leg weakness and colostasis
Published in Reumatologia clinica (01-05-2011)Get more information
Journal Article -
14
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
Published in Respiratory medicine (01-03-2021)“…The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or…”
Get full text
Journal Article Web Resource -
15
Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry
Published in Respiratory medicine (01-02-2021)“…The soluble guanylate cyclase stimulator riociguat is approved for the treatment of adult patients with pulmonary arterial hypertension (PAH) and inoperable or…”
Get full text
Journal Article Web Resource -
16
Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus
Published in Clinical and experimental rheumatology (01-03-2016)“…The objective of this study is to determine the prevalence of fibromyalgia (FM) in systemic lupus erythematosus (SLE) patients and to study its relationship to…”
Get full text
Journal Article -
17
Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER)
Published in Clinical and experimental rheumatology (01-11-2017)“…We aimed to describe juvenile-onset systemic lupus erythematosus (jSLE) features and to establish its differences compared to adult-onset SLE (aSLE) from a…”
Get full text
Journal Article -
18
Health Related Quality of Life in Rheumatoid Arthritis, Osteoarthritis, Diabetes Mellitus, End Stage Renal Disease and Geriatric Subjects. Experience From a General Hospital in Mexico
Published in Reumatología clinica (Barcelona) (01-03-2015)“…Chronic diseases have a great impact on the morbidity and mortality and on the health-related quality of life (HRQoL) of patients around the world. The impact…”
Get full text
Journal Article -
19
P149 Association between geographic and climatological conditions and cutaneous manifestations in lupus patients from the Spanish rheumatology society lupus registry cohort
Published in Lupus science & medicine (01-03-2020)“…Background/PurposeUltraviolet radiations act by modifying DNA in sun-exposed skin of lupus patients. We develop a study to analyze the association between…”
Get full text
Journal Article -
20
Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain
Published in Reumatología clinica (Barcelona) (01-09-2016)“…Several antibodies have proven to be useful in autoimmune diseases, as markers for diagnosis, prognosis or clinical manifestations. Our objective was to…”
Get full text
Journal Article